Article
Potential of facial biomarkers for Alzheimer’s disease and Obstructive sleep apnea in Down syndrome and general population
2024-11-07
Abstract excerpt
<h4>Background</h4> Down syndrome (DS) is caused by trisomy 21, leading to increased risks of Alzheimer’s disease (AD) and Obstructive sleep apnea (OSA). Traditional diagnostic methods for AD and OSA, like cerebrospinal fluid analysis and polysomnography, are invasive and challenging for people with DS. Facial morphology has emerged as a non-invasive biomarker for these conditions. Therefore, we conducted a compre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 85a0ddf3-daec-516b-a466-48adfedd453a
- DOI
- 10.1101/2024.11.03.24316427
